These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38504227)

  • 1. Light gradient boosting-based prediction of quality of life among oral cancer-treated patients.
    Ramalingam K; Yadalam PK; Ramani P; Krishna M; Hafedh S; Badnjević A; Cervino G; Minervini G
    BMC Oral Health; 2024 Mar; 24(1):349. PubMed ID: 38504227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of Life Assessment With European Organisation for Research and Treatment of Cancer Questionnaire (Head and Neck Module 43) and Its Clinicopathological Correlation Among Patients Treated for Oral Squamous Cell Carcinoma: An Exploratory Study.
    Ramalingam K; Krishnan M; Ramani P; Muthukrishnan A
    Cureus; 2023 Feb; 15(2):e34650. PubMed ID: 36895543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring quality of life among head-and-neck cancer patients in Western India using European organization for research and treatment of cancer questionnaires.
    Parkar S; Sharma A; Shah M
    J Cancer Res Ther; 2022; 18(4):990-996. PubMed ID: 36149151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The european organisation for research and treatment of cancer head and neck cancer module (EORTC QLQ-HN43): Estimates for minimal important difference and minimal important change.
    Singer S; Hammerlid E; Tomaszewska IM; Amdal CD; Herlofson BB; Santos M; Castro Silva J; Mehanna H; Fullerton A; Young T; Fernandez Gonzalez L; Inhestern J; Pinto M; Arraras JI; Yarom N; Bonomo P; Baumann I; Galalae R; Nicolatou-Galitis O; Kiyota N; Raber-Durlacher J; Salem D; Fabian A; Boehm A; Krejovic-Trivic S; Chie WC; Taylor KJ; Sherman AC; Licitra L; Machiels JP; Bjordal K;
    Eur J Cancer; 2024 Nov; 212():115062. PubMed ID: 39405647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale.
    Singer S; Hammerlid E; Tomaszewska IM; Amdal CD; Bjordal K; Herlofson BB; Santos M; Silva JC; Mehanna H; Fullerton A; Brannan C; Gonzalez LF; Inhestern J; Pinto M; Arraras JI; Yarom N; Bonomo P; Baumann I; Galalae R; Nicolatou-Galitis O; Kiyota N; Raber-Durlacher J; Salem D; Fabian A; Boehm A; Krejovic-Trivic S; Chie WC; Taylor K; Simon C; Licitra L; Sherman AC;
    Qual Life Res; 2022 Mar; 31(3):841-853. PubMed ID: 34272632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Assessment of the Quality of Life in Oral Squamous Cell Carcinoma Patients.
    G P; Ramalingam K; Ramani P; Krishnan M
    Cureus; 2024 May; 16(5):e60596. PubMed ID: 38894763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in patients with oral cancer treated by different reconstruction methods as measured by the EORTC QLQ-H&N43.
    Davudov MM; Harirchi I; Arabkheradmand A; Garajei A; Mirzajani Z; Amiraliyev K; Rustamli N; Zebardast J; Montazeri A
    Br J Oral Maxillofac Surg; 2020 Nov; 58(9):e67-e74. PubMed ID: 32646789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life of oral cancer patients after low-dose-rate interstitial brachytherapy.
    Yoshimura R; Shibuya H; Miura M; Watanabe H; Ayukawa F; Hayashi K; Toda K
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):772-8. PubMed ID: 18676096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translation and validation of Sinhala version of modified EORTC QLQ-OH15 in oral cancer patients who receive radiotherapy with or without chemotherapy in Sri Lanka.
    Kosgallana S; Jayasekara P; Abeysinghe P; Hjermstad M; Lalloo R
    BMC Oral Health; 2022 Aug; 22(1):359. PubMed ID: 35986341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of quality of life of patients 1-5 years after treatment for oral cancer.
    Khandelwal A; Neeli A; Gadiyar A; Khandelwal A
    Indian J Dent Res; 2017; 28(5):538-544. PubMed ID: 29072217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.
    Rischin D; Harrington KJ; Greil R; Soulières D; Tahara M; de Castro G; Psyrri A; Braña I; Neupane P; Bratland Å; Fuereder T; Hughes BGM; Mesía R; Ngamphaiboon N; Rordorf T; Ishak WZW; Hong RL; Mendoza RG; Jia L; Chirovsky D; Norquist J; Jin F; Burtness B
    Oral Oncol; 2022 May; 128():105815. PubMed ID: 35381576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of changes in EORTC QLQ-C30 scores to ratings on the Subjective Significance Questionnaire in men with localized prostate cancer.
    Rodrigues G; Bezjak A; Osoba D; Catton P; Tsuji D; Taylor D; Warde P
    Qual Life Res; 2004 Sep; 13(7):1235-46. PubMed ID: 15473502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life of head and neck cancer patients before and after cancer-directed treatment - A longitudinal study.
    Bashir A; Kumar D; Dewan D; Sharma R
    J Cancer Res Ther; 2020; 16(3):500-507. PubMed ID: 32719257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
    Marschner N; Wilke J; Reschke D; Kaiser F; Schmoor C; Grugel R; Boller E
    J Med Econ; 2018 Sep; 21(9):920-929. PubMed ID: 29874105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
    Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
    J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of liver function and quality of life of patients with liver cancer.
    Li L; Mo F; Hui EP; Chan SL; Koh J; Tang NLS; Yu SCH; Yeo W
    BMC Gastroenterol; 2019 May; 19(1):66. PubMed ID: 31046687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES Registry.
    Husson O; de Rooij BH; Kieffer J; Oerlemans S; Mols F; Aaronson NK; van der Graaf WTA; van de Poll-Franse LV
    Oncologist; 2020 Apr; 25(4):e722-e732. PubMed ID: 32297435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose-rate interstitial brachytherapy in oral cancer-Its impact on quality of life.
    Bajwa HK; Singareddy R; Alluri KR
    Brachytherapy; 2016; 15(3):381-386. PubMed ID: 26947320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer.
    Ripping TM; Rammant E; Witjes JA; Aaronson NK; van Hemelrijck M; van Hoogstraten LMC; ; Kiemeney LA; Aben KKH
    Health Qual Life Outcomes; 2022 Dec; 20(1):171. PubMed ID: 36581934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.